Barinthus Biotherapeutics (BRNS) EPS (Basic) (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly EPS (Basic) came in at -$0.14 in Q1 2026, up 72.25% YoY from -$0.08 in Q1 2025, and up 50.55% on a QoQ basis from -$0.27 in Q4 2025.
Barinthus Biotherapeutics (BRNS) EPS (Basic) (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of EPS (Basic) data on file, last reported at -$0.14 in Q1 2026.
- Quarterly EPS (Basic) rose 72.25% year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.28 (up 21.03% YoY) and the FY2025 annual result came in at -$1.64, down 5.46% from the prior year.
- EPS (Basic) improved to -$0.14 in Q1 2026, from -$0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.42 in Q2 2022 to a low of -$0.62 in Q2 2023.
- A 5-year average of -$0.3 and a median of -$0.4 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 209.18% — and 2023, when it plunged 792.65%.
- Tracing BRNS's EPS (Basic) over 5 years: stood at -$0.57 in 2022, then climbed by 20.72% to -$0.45 in 2023, then slipped by 16.18% to -$0.52 in 2024, then surged by 47.65% to -$0.27 in 2025, then surged by 50.55% to -$0.14 in 2026.
- The last three EPS (Basic) figures came in at -$0.14 (Q1 2026), -$0.27 (Q4 2025), and -$0.36 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Barinthus Biotherapeutics | 25.01 Mn | 25.01 Mn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.26 |
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.52 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.52 |
| Sep 30, 2024 | -0.21 |
| Jun 30, 2024 | -0.43 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.45 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.62 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | 0.22 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | -0.65 |
| Sep 30, 2021 | -0.20 |